邵诗颖-编委-开放获取期刊研究中心、开放获取期刊、开源期刊、学术期刊、电子期刊、中文期刊、开放获取-OAJRC-www.oajrc.org

欢迎来到OAJRC平台！

核心 CSCIED

期刊栏目

投稿

审稿

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据：

当前位置：首页 > 编委信息 > 编委详情

邵诗颖编委: 职称：副教授，副主任医师; 单位：华中科技大学同济医院内分泌科; 社会任职：中华医学会糖尿病学分会糖尿病与相关内分泌疾病学组委员，中华医学会糖尿病学分会糖尿病神经并发症学组委员，武汉医学会内分泌学分会委员，武汉医学会内分泌学分会糖尿病足学组副组长。

个人简介

邵诗颖，华中科技大学同济医院内分泌科，副教授，副主任医师，硕士生导师，医学博士。开展了多项糖尿病足创面修复的新技术，包括二代血小板凝胶技术，外源性细胞因子，局部氧疗技术等；优化糖尿病足多学科临床诊疗路径，包括疾病的诊断，分级，多学科协作，预后随访观察；开展糖尿病临床缓解的诊疗，优化缓解策略。

教育经历

▪1999.9-2006.7，同济医科大学同济医学院7年制，临床医学硕士学位，临床血液专业
▪2006.9-2009.10，新加坡国立大学医学院，Ph.D，糖尿病专业

学术贡献

1. Han Yue, Xiaoling Zhang, Zhiyi Zhao, Song Gong, Shiying Shao* (邵诗颖correspondence). Pro-healing impact of liraglutide on skin wounds in normoglycemic mice. Int Immunopharmacol. 2025 Feb 6;147:114050. (IF 5.7, Q2)
2. Min Yang, Han Yue, Qinqin Xu, Shiying Shao* (邵诗颖co-correspondence), Yong Chen*. Pioglitazone reduces serum ketone bodies in sodium-glucose cotransporter-2 inhibitor-treated non-obese type 2 diabetes: A single-centre, randomized, crossover trial. Diabetes Obes Metab. 2024 Aug;26(8):3137-3146. (IF 6.6, Q1)
3. Fen Wang, Xiaoling Zhang, Jing Zhang, Qinqin Xu, Xuefeng Yu, Anhui Xu, Chengla Yi, Xuna Bian, Shiying Shao* (邵诗颖correspondence). Recent Advances in the Adjunctive Management of Diabetic Foot Ulcer: Focus on Non-invasive technologies. Med Res Rev. 2024 Jul;44(4):1501-1544. (IF 13.3, Q1)
4. Fen Wang, Xiaoling Zhang, Jing Zhang, Song Gong, Jing Tao, Hui Xiang, Xiaoqing Fu, Xuna Bian, Xuefeng Yu, Anhui Xu, Chenla Yi, Shiying Shao* (邵诗颖correspondence). Therapeutic Effectiveness of Leukocyte- and Platelet-rich Fibrin for Diabetic Foot Ulcers: A Retrospective Study. Curr Med Sci. 2024 Jun;44(3):568-577. (IF 2.6, Q3)
5. Xiaoling Zhang, Jing Tao, Song Gong, Xuefeng Yu, Shiying Shao* (邵诗颖 correspondence). Effects of Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor on Diabetic Lower Extremity Ulcers: Case Series of Nine Patients. Diabetes Metab Syndr Obes. 2024 May 7;17:1941-1956. (IF 3.3, Q3)
6. Qinqin Xu, Xiaoling Zhang, Ban Luo, Tao Li, Gang Yuan, Shiying Shao* (邵诗颖correspondence). Role of Peripheral Regulatory T Lymphocytes in Patients with Thyroid Associated Ophthalmopathy During Systemic Glucocorticoid Treatment: A Prospective Observational Study. 2023 Feb;43(1):130-138. (IF 2.6, Q3)
7. Cunyu Li, Jing Zhang, Fen Wang, Weili Li, Qinqin Xu, Shiying Shao* (邵诗颖 correspondence). Leukocyte- and platelet-rich fibrin treatment of chronic lower extremity ulcer in a patient with systemic lupus erythematosus: a case report. Wounds. 2023 Jan;35(1):E1-E6. (IF 1.7, Q3)
8. Shiying Shao* (邵诗颖correspondence), Xinwu Ran, Jibiao Li. Editorial: Diabetic wound: Multifaceted mechanisms and future of diabetic wound healing. Front Endocrinol (Lausanne). 2023 Jan 9;13:1068921. (IF 6.1, Q2)
9. Qinqin Xu, Xiaoling Zhang, Tao Li*, Shiying Shao* (邵诗颖co-correspondence). Exenatide regulates Th17/Treg balance via PI3K/Akt/FoxO1 pathway in db/db mice. Mol Med. 2022 Dec 3;28(1):144. (IF 6.4, Q1)
10. Shiying Shao (邵诗颖), Xiaoling Zhang, Qinqin Xu, Ruping Pan, Yong Chen. Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities. Pharmacol Ther. 2022 Nov;239:108270. (IF 13.5, Q1)
11. Fuqiong Chen, Qinqin Xu, Wenzhu Yue, Xuefeng Yu, Shiying Shao* (邵诗颖correspondence). A MEN1 Patient Presenting With Multiple Parathyroid Adenomas and Transient Hypercortisolism: A Case Report and Literature Review. Front Endocrinol (Lausanne). 2022 Mar 8;13:802453. (IF 6.1, Q2)
12. Yan Yang, Qinqin Xu, Tao Li*, Shiying Shao* (邵诗颖co-correspondence). Trimetazidine ameliorates hindlimb ischaemic damage in type 2 diabetic mice. Ann Med. 2021 Dec;53(1):1099-1107. (IF 5.3, Q1)
13. Mei Guo, Qinqin Xu, Xuefeng Yu, Qin Yang*, Shiying Shao* (邵诗颖co-correspondence). Association of Agenesis of the Dorsal Pancreas With HNF1B Heterozygote Mutation: A Case Report. Front Endocrinol (Lausanne). 2021 Oct 15;12:640006. (IF 6.1, Q2)
14. Shiying Shao (邵诗颖), Qin Yang, Ruping Pan, Xuefeng Yu, Yong Chen. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes. Front Endocrinol (Lausanne). 2021 Oct 6;12:731974. (IF 6.1, Q2)
15. Shiying Shao (邵诗颖), Ruping Pan, Yong Chen*. Autologous platelet-rich plasma for diabetic foot ulcer. Trends Endocrin Met. 2020 Dec;31(12):885-890. (IF 12.0, Q1)
16. Shiying Shao (邵诗颖), Qinqin Xu, Xuefeng Yu, Ruping Pan, Yong Chen*. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions. Pharmacol Ther. 2020 May;209:107503. (IF 13.5, Q1)
17. Xinyue Zhang, Yan Yang, Shiying Shao* (邵诗颖correspondence). Acquired reactive perforating collagenosis: a case report and review of the literature. Medicine (Baltimore). 2020 May 29;99(22):e20391. (IF 1.9, Q2)
18. Chunyu Li, Fuqiong Chen, Xuefeng Yu, Shuhong Hu*, Shiying Shao* (邵诗颖co-correspondence). A silent myocardial infarction with normal coronary arteries associated with Graves' disease. Heart Lung. 2019 Jul-Aug;48(4):347-350. (IF 2.4, Q2)
19. Mei Wang, Fuqiong Chen, Jinli Wang, Zhixuan Zeng, Qin Yang*, Shiying Shao* (邵诗颖co-correspondence). Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients. Clin Immunol. 2018 Sep 13;197:77-85 (IF 10.2, Q2)
20. Shiying Shao# (邵诗颖) Zeng Zhixuan#, Hu Shuhong. An observational analysis of insulinoma from 1 single institution. QJM. 2018 Apr 1;111(4):237-241. (IF 14.0, Q1)

工作经历

2015/11-至今，华中科技大学，同济医院，副教授，副主任医师

2009/10-2015/11，华中科技大学，同济医院，讲师，主治医师

2013/10-2014/10，瑞士苏黎世联邦理工学院，IMSB，访问学者

入驻平台

回到顶部

搜索文章: